EPO, erythropoietin, 2056

N. diseases: 646; N. variants: 11
Disease: Cognition Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders 		0.320 Biomarker group BEFREE These results support the observations that pretreatment with EPO reduced long-term cognitive deficits and neuronal degeneration in cortex and hippocampus induced by sevoflurane exposure with low oxygen concentration in neonatal rats. 30953276 2019
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders 		0.320 Biomarker group BEFREE This preliminary study found that adjunctive EPO appears to be effective in treating cognitive deficits associated with schizophrenia, bipolar disorder, and major depression without major adverse effects observed. 28718181 2018
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders 		0.320 Therapeutic group CTD_human Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury. 20833152 2010